Fresh Tracks Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Fresh Tracks Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2023.
  • Fresh Tracks Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $6.57M.
  • Fresh Tracks Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $6.53M, a 454% increase from 2022.
  • Fresh Tracks Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.18M, a 96.4% decline from 2021.
  • Fresh Tracks Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $33M, a 14.3% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $6.57M +$6.62M Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q1 2022 -$55K -$10.7M -101% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $10.6M +$8.59M +429% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $2.01M +$1.49M +286% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $520K +$519K +51900% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q1 2018 $1K* Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q1 2014 -$29K -$254K -113% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-02
Q1 2013 $225K -$48.4M -99.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q1 2012 $48.7M +$48.7M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 -$63K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.